Start a New Search
SHOWING 216 RESULTS
We strongly believe that financial transparency of federal award funds is essential to insuring public trust.
Reducing Regulatory Burden | Research Administration & Regulation | LettersHigher education associations, write to House and Senate members to urge them to include extensions of the above-the-line deduction for qualified tuition and related expenses (tuition deduction) and the Individual Retirement Account (IRA) Charitable Rollover in any tax extenders legislation that is…
Taxation & Finance | Student Aid Tax Issues | Endowments and Charitable Giving | LettersYour new bill focuses on improving data standards and reporting, as well as streamlining financial reporting.
Reducing Regulatory Burden | Research Administration & Regulation | LettersThe nation's top research universities and AAMC issued a set of shared guidelines intended to protect the public interest when universities grant licenses for the rights to their latest scientific advances to private parties.
Intellectual Property | Technology Transfer | Research Administration & Regulation | Stanford University | Press ReleasesExpired & Expiring Tax Provisions Important to Research Universities.
Taxation & Finance | Student Aid Tax Issues | Endowments and Charitable Giving | AnalysisFacts about College and University Endowments, 2009.
Taxation & Finance | Endowments and Charitable Giving | Fact SheetsThose concerns have centered on the imposition of redundant and costly reporting requirements. The revised bill would eliminate explicitly duplicative reporting within three years.
Research Administration & Regulation | Reducing Regulatory Burden | LettersAAU, APLU, COGR letter on proposed changes to NIH guidelines for human stem cell research and consideration of certain human-animal chimera research.
Research Administration & Regulation | National Institutes of Health | LettersRe: Retrospective Review: Identifying and Reducing Regulatory Burdens; 81 FR 4213
Research Administration & Regulation | Reducing Regulatory Burden | LettersIn the US, ketamine is currently a Schedule III drug under the Controlled Substances Act, and strict regulations and safeguards are already in place to prevent its illegal use.
Research Administration & Regulation | Reducing Regulatory Burden | Higher Education Regulation | Letters